These balanced responses are fine-tuned by host factors at multiple levels and loss of this fine-tuning can result in sustained IFN signaling, immunosuppression and tissue damage, which has been implicated in pathogenesis of chronic viral infections, autoimmune diseases and cancer [18]. The gene discussed is IFNA1; the disease is cancer.